2009
DOI: 10.1002/jmri.21975
|View full text |Cite
|
Sign up to set email alerts
|

Nephrogenic systemic fibrosis: Clinical spectrum of disease

Abstract: Nephrogenic systemic fibrosis (NSF) is a rare systemic fibrosing disorder that primarily affects the skin and the subcutaneous structures. Also, there are reports of involvement of deeper structures and organs in the human body, but the confirmation of systemic involvement is complicated by overlap of other disease processes that occur in patients with severe renal impairment. The disorder leads to significant disability and is an important contributing factor of death. Virtually all patients who developed NSF… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 68 publications
0
14
0
Order By: Relevance
“…This might facilitate clinical translation compared to other pH imaging agents, where toxic effects can arise from Gd 3+ -chelates in patients with renal insufficiency29 or from preparations of hyperpolarized caesium bicarbonate, where toxic caesium30 is used to increase the bicarbonate concentration.…”
Section: Discussionmentioning
confidence: 99%
“…This might facilitate clinical translation compared to other pH imaging agents, where toxic effects can arise from Gd 3+ -chelates in patients with renal insufficiency29 or from preparations of hyperpolarized caesium bicarbonate, where toxic caesium30 is used to increase the bicarbonate concentration.…”
Section: Discussionmentioning
confidence: 99%
“…The natural history of NSF is variable [19]. As the condition progresses, the skin may take on a woody texture.…”
Section: How Serious a Problem Is Nsf?mentioning
confidence: 99%
“…In the vast majority of patients, gadolinium contrast agents are safe—safer than iodine-based contrast. However, in patients with an estimated glomerular filtration rate of <30 mL/min, only cyclic gadolinium-based contrast agents should be used, and then only after risk-benefit analysis and at the minimum dose because of the possibility of the severe condition, nephrogenic systemic fibrosis (NSF) [10]. …”
Section: Cmr Safetymentioning
confidence: 99%